Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy

Chimeric antigen receptor T (CAR-T) cells show good efficacy in the treatment of relapsed and refractory B-cell tumors, such as acute B-cell leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). The main toxicities of CAR-T include cytokine release syndrome, immune effector cell-associated neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Limin, Wang, Yihao, Liu, Hui, Gao, Shan, Shao, Qing, Yue, Lanzhu, Liu, Zhaoyun, Wang, Huaquan, Shao, Zonghong, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733571/
https://www.ncbi.nlm.nih.gov/pubmed/35004324
http://dx.doi.org/10.3389/fonc.2021.798352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733571/
https://www.ncbi.nlm.nih.gov/pubmed/35004324
http://dx.doi.org/10.3389/fonc.2021.798352

Ejemplares similares